Abiopharma

News list

Director MOHR MARSHALL 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000004

Full text

News bot Sept. 3, 2025, 11:07 p.m.
🔍 MOHR MARSHALL (Director)

Company: VEEVA SYSTEMS INC (VEEV)

Report Date: 2025-09-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 289
- Total shares sold: 289
Detailed Transactions and Holdings:
- Acquired 289 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,110.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 289 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 866.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3, F3
Footnotes:
- F1: Transaction Exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
- F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
- F3: On June 18, 2025, the Reporting Person was granted 1,155 RSUs under the Issuer's Amended & Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2025, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.